|
Acquisition Purchase Price Allocation (Details) (USD $)
|
0 Months Ended | |||
|---|---|---|---|---|
|
Oct. 31, 2014
|
Dec. 31, 2014
|
Dec. 31, 2013
|
Aug. 31, 2013
|
|
| Business Acquisition [Line Items] | ||||
| Contingent consideration | $ 26,542,000us-gaap_BusinessCombinationContingentConsiderationLiability | $ 500,000us-gaap_BusinessCombinationContingentConsiderationLiability | ||
| Goodwill | 15,545,000us-gaap_Goodwill | 0us-gaap_Goodwill | ||
| RedPath Integrated Pathology, Inc | ||||
| Business Acquisition [Line Items] | ||||
| Cash |
13,572,000us-gaap_PaymentsToAcquireBusinessesGross / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember |
|||
| Cash |
22,066,000us-gaap_BusinessCombinationConsiderationTransferredOther1 / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember |
|||
| Common stock |
1,820,000us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember |
|||
| Contingent consideration |
23,886,000us-gaap_BusinessCombinationContingentConsiderationLiability / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember |
|||
| Total consideration |
44,854,000us-gaap_BusinessCombinationConsiderationTransferred1 / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember |
|||
| Goodwill |
15,545,000us-gaap_Goodwill / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember |
|||
| Acquired intangible assets |
34,492,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember |
|||
| Current assets |
5,465,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember |
|||
| Other long-term assets |
366,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember |
|||
| Current liabilities |
(4,809,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember |
|||
| Deferred income tax liability |
(6,205,000)us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember |
|||
| Total acquired assets |
44,854,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember |
|||
| Diagnostic Test - Pancreas | RedPath Integrated Pathology, Inc | ||||
| Business Acquisition [Line Items] | ||||
| Acquired intangible assets |
16,141,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = pdii_DiagnosticTestPancreasMember |
|||
| Diagnostic Test - Barrett's RedPath | RedPath Integrated Pathology, Inc | ||||
| Business Acquisition [Line Items] | ||||
| Acquired intangible assets |
18,351,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis = pdii_DiagnosticTestBarrettsRedPathMember |
|||
| Notes Payable, Other Payables | ||||
| Business Acquisition [Line Items] | ||||
| Subordinated note payable |
11,000,000us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember |
|||
| Notes Payable, Other Payables | RedPath Integrated Pathology, Inc | ||||
| Business Acquisition [Line Items] | ||||
| Subordinated note payable |
$ 7,396,000us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred / us-gaap_BusinessAcquisitionAxis = pdii_RedPathIntegratedPathologyIncMember / us-gaap_LongtermDebtTypeAxis = us-gaap_NotesPayableOtherPayablesMember |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of tangible or intangible assets, including a business or subsidiary of the acquirer transferred by the entity to the former owners of the acquiree. Excludes cash. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of identifiable intangible assets recognized as of the acquisition date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|